HRP20180709T1
(en)
|
|
Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
|
CY2020008I2
(en)
|
|
PHARMACEUTICAL FORMS OF DISTROMAT TABLET
|
BR112012011902A2
(en)
|
|
pharmaceutical capsule
|
HK1259250A1
(en)
|
|
Pharmaceutical formulations comprising 1-(beta-d-glucopyranosyl)-2-thienylmethylbenzene derivatives
|
DK2632493T3
(en)
|
|
Drug Administration Compositions
|
FR2949470B1
(en)
|
|
ANTICANCER DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
|
DK3045164T3
(en)
|
|
Aqueous pharmaceutical compositions containing borate-polyol complexes
|
EP2429506A4
(en)
|
|
Coated pharmaceutical capsule dosage form
|
DK3284467T3
(en)
|
|
Nicotine-containing pharmaceutical compositions
|
BRPI1009324A2
(en)
|
|
and / or pharmaceutically acceptable compounds thereof, pharmaceutical composition and their uses
|
BRPI1014027A2
(en)
|
|
stable nanoparticle drug suspension.
|
FR2963007B1
(en)
|
|
ANTICANCER DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
|
FR2948568B1
(en)
|
|
PHARMACEUTICAL FORMULATION
|
IL216113A
(en)
|
|
Substituted indazole and aza-indazole derivatives, pharmaceutical compositions comprising them and uses thereof
|
IT1404931B1
(en)
|
|
OPHTHALMIC COMPOSITIONS FOR THE ADMINISTRATION OF LIPO-SOLUBLE ACTIVE PRINCIPLES.
|
BRPI1016190A2
(en)
|
|
pharmaceutical compounds.
|
DK2391349T3
(en)
|
|
Pharmaceutical composition comprising 2-oco-1-pyrrolidine derivatives
|
BR112012000831A2
(en)
|
|
related compounds, pharmaceutical compositions and methods
|
DK2313087T4
(en)
|
|
IMMEDIATE RELEASE PHARMACEUTICAL DOSAGE FORM OF AN INDOLINE DERIVATIVE
|
DK2391351T3
(en)
|
|
Pharmaceutical composition comprising 2-oxo-1-pyrrolidine derivatives
|
BRPI0922653A2
(en)
|
|
pharmaceutical preparation
|
EA201200616A1
(en)
|
|
DERIVATIVES 2-OXO-1-PIRROLIDININILIMIDAZOTHIAADIA ASOL
|
IL233199B
(en)
|
|
Heterocyclic carboxamide derivatives, their preparation and pharmaceutical compositions containing them
|
CO6771413A2
(en)
|
|
Diphenylamine derivatives: uses, synthesis procedure and pharmaceutical compositions
|
BR112013014606A2
(en)
|
|
pharmaceutical compositions comprising alisporivir, their use, and capsule
|